Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProjetoS: Effectiveness of Sinovac COVID-19 Vaccine in Serrana
NCT04747821Phase 4Completed
- Sponsor
- Instituto Butantan
- Start
- Feb 2021
- Primary completion
- Mar 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Instituto Butantan. Started Feb 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04747821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747821.